Skip to Content

Venture Capitalists Love Biotech Right Now

Scientific advances and new business models are spurring investor confidence in biomedical-related ventures.
February 24, 2015

Venture capital investment in U.S. life sciences companies soared 29 percent in 2014 from the year before, reaching $8.6 billion, the highest level since 2007. And there is reason to think 2015 will also be a big year for a sector having its third boom of the last two decades.

Biotech is the second biggest category for venture investment after software. VCs are gaining confidence in life sciences companies (which include those developing new drugs and therapies as well as those that make medical devices and equipment) partly because their underlying research has advanced significantly, says Greg Vlahos, life sciences partner at PricewaterhouseCoopers, which published the new numbers. A big spike in IPOs by biotech companies over the past two years has also made the field more enticing.

Distinguishing 2014 from the booms in 2000 and 2007, says Vlahos, was the record number of “megadeals” of over $100 million. The $446 million investment round in Moderna Therapeutics, which is developing a novel class of drugs based on messenger RNA (see “Messenger RNA Could Create a New Class of Drugs”), was the largest Vlahos’s group has ever seen for a life sciences company. 

Keep Reading

Most Popular

A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?

Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.

A startup says it’s begun releasing particles into the atmosphere, in an effort to tweak the climate

Make Sunsets is already attempting to earn revenue for geoengineering, a move likely to provoke widespread criticism.

10 Breakthrough Technologies 2023

Every year, we pick the 10 technologies that matter the most right now. We look for advances that will have a big impact on our lives and break down why they matter.

These exclusive satellite images show that Saudi Arabia’s sci-fi megacity is well underway

Weirdly, any recent work on The Line doesn’t show up on Google Maps. But we got the images anyway.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.